9MW2821

· Mabwell (Shanghai) Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for 9MW2821, covering 2022-06-15 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: NECTAR Study: Neoadjuvant Toripalimab + 9MW2821 for Local UTUC [Phase 2]